
Weibin Zhou, PhD
About Me
The long-term goal of Dr. Zhou’s research is to understand the pathogenic mechanisms and develop therapies of kidney diseases using zebrafish pronephros (embryonic fish kidney) and mesonephros (adult fish kidney) as an animal model system. His ongoing projects are: (1) using haploid zebrafish to screen for genetic modifiers of polycystic kidney disease (2) functional characterization of candidate modifier genes for diabetic nephropathy using a zebrafish model of insulin insufficiency and hyperglycemia. (3) functional test of candidate genes associated with chronic kidney diseases identified through computational analyses of single-cell transcriptome.
Language
English
Position
ASSISTANT PROFESSOR | Pharmacological Sciences
Research Topics
Developmental Neurobiology, Diabetes, Genetics, Kidney, Molecular Biology, Neuro-degeneration/protection
Education
PhD, University of Michigan
, University of Michigan
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Zhou has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.